Analysis of 195 parotid neoplasm cases at UOPECCAN`s Hospital
DOI:
https://doi.org/10.33448/rsd-v12i9.43329Keywords:
Parotid gland; Parotid neoplasms; Adenolymphoma; Adenoma, pleomorphic; Head and neck neoplasms.Abstract
Introduction: parotid gland neoplasms correspond to most neoplasms that affect the salivary glands, having different histological types. Among them, the most common are Warthin's tumor and pleomorphic adenoma. Each histological type has different risk factors and predominance in different genders. Objective: this study aims to retrospectively analyze patients diagnosed with parotid neoplasms, seeking to identify anatomopathological characteristics, incidence in relation to age group and sex, possible risk factors, treatments performed and postoperative complications in the period from 2014 to 2020. at the Cascavel Cancer Hospital - União Oeste Paranaense de Combate ao Câncer - Uopeccan. Methods: 195 medical records were analyzed, all from 2014 to 2020, from these records the necessary data for this study were taken and tabulated, with the objective of defining the profile of the patients studied. Results: The most frequent malignant neoplasm was SCC- (metastatic squamous cell carcinoma). Warthin's Tumor has also been shown to be strongly associated with smoking. Conclusion: the profile of the patients at Hospital Uopeccan correspond to the profile of the world literature, however there was a higher incidence of metastatic SCC in relation to mucoepidermoid carcinoma. A possible risk factor for Warthin’s Tumor would be smoking. The most commonly presented primary malignant neoplasm was carcinoma ex pleomorphic adenoma.
References
Audet, N., Palme, C. E., Gullane, P. J., Gilbert, R. W., Brown, D. H., Irish, J., & Neligan, P. (2004). Cutaneous metastatic squamous cell carcinoma to the parotid gland: analysis and outcome. Head & neck, 26(8), 727–732. https://doi.org/10.1002/hed.20048
Chang, J. W., Hong, H. J., Ban, M. J., Shin, Y. S., Kim, W. S., Koh, Y. W., & Choi, E. C. (2015). Prognostic Factors and Treatment Outcomes of Parotid Gland Cancer: A 10-Year Single-Center Experience. Otolaryngology--head and neck surgery: official journal of American Academy of Otolaryngology-Head and Neck Surgery, 153(6), 981–989. https://doi.org/10.1177/0194599815594789
Clark, J., & Wang, S. (2016). Metastatic Cancer to the Parotid. Advances in oto-rhino-laryngology, 78, 95–103. https://doi.org/10.1159/000442129
Cracchiolo, J. R., & Shaha, A. R. (2016). Parotidectomy for Parotid Cancer. Otolaryngologic clinics of North America, 49(2), 415–424. https://doi.org/10.1016/j.otc.2015.10.007
Franzen, A., Buchali, A., & Lieder, A. (2017). The rising incidence of parotid metastases: our experience from four decades of parotid gland surgery. Incremento dell’incidenza di metastasi alla ghiandola parotide: analisi della nostra esperienza in quattro decenni di chirurgia parotidea. Acta otorhinolaryngologica Italica: organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale, 37(4), 264–269. https://doi.org/10.14639/0392-100X-1095
Franzen, A., Lieder, A., Guenzel, T., & Buchali, A. (2019). The Heterogenicity of Parotid Gland Squamous Cell Carcinoma: A Study of 49 Patients. In vivo (Athens, Greece), 33(6), 2001–2006. https://doi.org/10.21873/invivo.11696
Fronteira, I. (2013). Observational Studies in the Era of Evidence Based Medicine: Short Review on their Relevance, Taxonomy and Designs. Acta Médica Portuguesa, 26(2), 161–170. https://doi.org/10.20344/amp.3975
Ho, K., Lin, H., Ann, D. K., Chu, P. G., & Yen, Y. (2011). An overview of the rare parotid gland cancer. Head & neck oncology, 3, 40. https://doi.org/10.1186/1758-3284-3-40
Jeannon, J. P., Calman, F., Gleeson, M., McGurk, M., Morgan, P., O'Connell, M., Odell, E., & Simo, R. (2009). Management of advanced parotid cancer. A systematic review. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 35(9), 908–915. https://doi.org/10.1016/j.ejso.2008.10.009
Lewis, A. G., Tong, T., & Maghami, E. (2016). Diagnosis and Management of Malignant Salivary Gland Tumors of the Parotid Gland. Otolaryngologic clinics of North America, 49(2), 343–380. https://doi.org/10.1016/j.otc.2015.11.001
Matos, F.C.M & Vasconcellos, V.M. (2022) SBCCP course – Qualification for mapping of cranial nerves in head and neck surgery – intraoperative facial nerve monitoring. 51(1), 1-4. https://doi.org/10.4322/ahns.2022.0001
Merchán-Hamann, E., & Tauil, P. L. (2021). Proposta de classificação dos diferentes tipos de estudos epidemiológicos descritivos. Epidemiologia E Serviços De Saúde, 30(1), e2018126. https://doi.org/10.1590/s1679-49742021000100026
Meyer, M. F., Wolber, P., Arolt, C., Wessel, M., Quaas, A., Lang, S., Klussmann, J. P., Semrau, R., & Beutner, D. (2021). Survival after parotid gland metastases of cutaneous squamous cell carcinoma of the head and neck. Oral and maxillofacial surgery, 25(3), 383–388. https://doi.org/10.1007/s10006-020-00934-8
Pinkston, J. A., & Cole, P. (1999). Incidence rates of salivary gland tumors: results from a population-based study. Otolaryngology--head and neck surgery: official journal of American Academy of Otolaryngology-Head and Neck Surgery, 120(6), 834–840. https://doi.org/10.1016/S0194-5998(99)70323-2
Pohar, S., Gay, H., Rosenbaum, P., Klish, D., Bogart, J., Sagerman, R., Hsu, J., & Kellman, R. (2005). Malignant parotid tumors: presentation, clinical/pathologic prognostic factors, and treatment outcomes. International journal of radiation oncology, biology, physics, 61(1), 112–118. https://doi.org/10.1016/j.ijrobp.2004.04.052
Spiro R. H. (1986). Salivary neoplasms: overview of a 35-year experience with 2,807 patients. Head & neck surgery, 8(3), 177–184. https://doi.org/10.1002/hed.2890080309
Stafford, N. D., & Wilde, A. (1997). Parotid cancer. Surgical oncology, 6(4), 209–213. https://doi.org/10.1016/s0960-7404(98)00008-5
Stubbs, V. C., Rajasekaran, K., Cannady, S. B., Newman, J. G., Ibrahim, S. A., & Brant, J. A. (2020). Social determinants of health and survivorship in parotid cancer: An analysis of the National Cancer Database. American journal of otolaryngology, 41(1), 102307. https://doi.org/10.1016/j.amjoto.2019.102307
Swendseid, B., Li, S., Thuener, J., Rezaee, R., Lavertu, P., Fowler, N., & Zender, C. (2017). Incidence of facial nerve sacrifice in parotidectomy for primary and metastatic malignancies. Oral oncology, 73, 43–47. https://doi.org/10.1016/j.oraloncology.2017.07.029
Toonkel, L. M., Guha, S., Foster, P., & Dembrow, V. (1994). Radiotherapy for parotid cancer. Annals of surgical oncology, 1(6), 468–472. https://doi.org/10.1007/BF02303611
Wu, S., Liu, G., Chen, R., & Guan, Y. (2012). Role of ultrasound in the assessment of benignity and malignancy of parotid masses. Dento maxillo facial radiology, 41(2), 131–135. https://doi.org/10.1259/dmfr/60907848
Zhan, K. Y., Khaja, S. F., Flack, A. B., & Day, T. A. (2016). Benign Parotid Tumors. Otolaryngologic clinics of North America, 49(2), 327–342. https://doi.org/10.1016/j.otc.2015.10.005
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Gabriel Massahiro Nagai; Paulo Henrique Dondoni; Hildebrando Massahiro Nagai; Peterson Fasolo Bilhar; Amabile Andreetta
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
